Suppr超能文献

发现EED的拟肽配体作为PRC2的变构抑制剂

Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.

作者信息

Barnash Kimberly D, The Juliana, Norris-Drouin Jacqueline L, Cholensky Stephanie H, Worley Beau M, Li Fengling, Stuckey Jacob I, Brown Peter J, Vedadi Masoud, Arrowsmith Cheryl H, Frye Stephen V, James Lindsey I

机构信息

Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599, United States.

Structural Genomics Consortium, University of Toronto , Toronto, Ontario M5G 1L7, Canada.

出版信息

ACS Comb Sci. 2017 Mar 13;19(3):161-172. doi: 10.1021/acscombsci.6b00174. Epub 2017 Feb 22.

Abstract

The function of EED within polycomb repressive complex 2 (PRC2) is mediated by a complex network of protein-protein interactions. Allosteric activation of PRC2 by binding of methylated proteins to the embryonic ectoderm development (EED) aromatic cage is essential for full catalytic activity, but details of this regulation are not fully understood. EED's recognition of the product of PRC2 activity, histone H3 lysine 27 trimethylation (H3K27me3), stimulates PRC2 methyltransferase activity at adjacent nucleosomes leading to H3K27me3 propagation and, ultimately, gene repression. By coupling combinatorial chemistry and structure-based design, we optimized a low-affinity methylated jumonji, AT-rich interactive domain 2 (Jarid2) peptide to a smaller, more potent peptidomimetic ligand (K = 1.14 ± 0.14 μM) of the aromatic cage of EED. Our strategy illustrates the effectiveness of applying combinatorial chemistry to achieve both ligand potency and property optimization. Furthermore, the resulting ligands, UNC5114 and UNC5115, demonstrate that targeted disruption of EED's reader function can lead to allosteric inhibition of PRC2 catalytic activity.

摘要

胚胎外胚层发育蛋白(EED)在多梳抑制复合物2(PRC2)中的功能是由一个复杂的蛋白质-蛋白质相互作用网络介导的。甲基化蛋白与胚胎外胚层发育蛋白(EED)芳香笼结合对PRC2的变构激活对于其完全催化活性至关重要,但这种调控的细节尚未完全了解。EED对PRC2活性产物组蛋白H3赖氨酸27三甲基化(H3K27me3)的识别,会刺激PRC2甲基转移酶在相邻核小体上的活性,导致H3K27me3的传播,并最终导致基因抑制。通过结合组合化学和基于结构的设计,我们将低亲和力的甲基化Jumonji、富含AT的相互作用结构域2(Jarid2)肽优化为一种更小、更有效的EED芳香笼拟肽配体(K = 1.14 ± 0.14 μM)。我们的策略说明了应用组合化学实现配体效力和性质优化的有效性。此外所得配体UNC5114和UNC5115表明,靶向破坏EED的读取功能可导致PRC2催化活性的变构抑制。

相似文献

1
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2.
ACS Comb Sci. 2017 Mar 13;19(3):161-172. doi: 10.1021/acscombsci.6b00174. Epub 2017 Feb 22.
2
Discovery of selective activators of PRC2 mutant EED-I363M.
Sci Rep. 2019 Apr 25;9(1):6524. doi: 10.1038/s41598-019-43005-z.
3
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.
Nat Chem Biol. 2017 Apr;13(4):381-388. doi: 10.1038/nchembio.2304. Epub 2017 Jan 30.
4
Binding Modes of Small-Molecule Inhibitors to the EED Pocket of PRC2.
Chemphyschem. 2020 Feb 4;21(3):263-271. doi: 10.1002/cphc.201900903. Epub 2020 Jan 16.
5
Discovery and Molecular Basis of a Diverse Set of Polycomb Repressive Complex 2 Inhibitors Recognition by EED.
PLoS One. 2017 Jan 10;12(1):e0169855. doi: 10.1371/journal.pone.0169855. eCollection 2017.
6
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.
Nat Chem Biol. 2017 Apr;13(4):389-395. doi: 10.1038/nchembio.2306. Epub 2017 Jan 30.
7
Embryonic Ectoderm Development (EED) as a Novel Target for Cancer Treatment.
Curr Top Med Chem. 2021;21(31):2771-2777. doi: 10.2174/1568026621666210920154942.
8
Allosteric Inactivation of Polycomb Repressive Complex 2 (PRC2) by Inhibiting Its Adapter Protein: Embryonic Ectodomain Development (EED).
J Med Chem. 2017 Mar 23;60(6):2212-2214. doi: 10.1021/acs.jmedchem.7b00287. Epub 2017 Mar 3.
9
Diverse, Potent, and Efficacious Inhibitors That Target the EED Subunit of the Polycomb Repressive Complex 2 Methyltransferase.
J Med Chem. 2021 Dec 9;64(23):17146-17183. doi: 10.1021/acs.jmedchem.1c01161. Epub 2021 Nov 22.

引用本文的文献

2
Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer.
Front Oncol. 2023 Oct 16;13:1216289. doi: 10.3389/fonc.2023.1216289. eCollection 2023.
3
The roles of EZH2 in cancer and its inhibitors.
Med Oncol. 2023 May 6;40(6):167. doi: 10.1007/s12032-023-02025-6.
4
Discovery of Potent Peptidomimetic Antagonists for Heterochromatin Protein 1 Family Proteins.
ACS Omega. 2021 Dec 22;7(1):716-732. doi: 10.1021/acsomega.1c05381. eCollection 2022 Jan 11.
5
Systematic Variation of Both the Aromatic Cage and Dialkyllysine via GCE-SAR Reveal Mechanistic Insights in CBX5 Reader Protein Binding.
J Med Chem. 2022 Feb 10;65(3):2646-2655. doi: 10.1021/acs.jmedchem.1c02049. Epub 2022 Jan 11.
6
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation.
NAR Cancer. 2021 Oct 4;3(4):zcab039. doi: 10.1093/narcan/zcab039. eCollection 2021 Dec.
7
A Peptidomimetic Ligand Targeting the Chromodomain of MPP8 Reveals HRP2's Association with the HUSH Complex.
ACS Chem Biol. 2021 Sep 17;16(9):1721-1736. doi: 10.1021/acschembio.1c00429. Epub 2021 Aug 20.
8
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders.
J Med Chem. 2021 Aug 26;64(16):11774-11797. doi: 10.1021/acs.jmedchem.1c00226. Epub 2021 Aug 5.
9
Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain Finger Protein 1 (PHF1).
J Med Chem. 2021 Jun 24;64(12):8510-8522. doi: 10.1021/acs.jmedchem.1c00430. Epub 2021 May 17.
10
Identification of novel EED-EZH2 PPI inhibitors using an in silico fragment mapping method.
J Comput Aided Mol Des. 2021 May;35(5):601-611. doi: 10.1007/s10822-021-00378-6. Epub 2021 Feb 26.

本文引用的文献

1
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase.
J Med Chem. 2017 Jan 12;60(1):415-427. doi: 10.1021/acs.jmedchem.6b01473. Epub 2017 Jan 3.
2
Chromodomain Ligand Optimization via Target-Class Directed Combinatorial Repurposing.
ACS Chem Biol. 2016 Sep 16;11(9):2475-83. doi: 10.1021/acschembio.6b00415. Epub 2016 Jul 14.
5
Selective Inhibition of CBX6: A Methyllysine Reader Protein in the Polycomb Family.
ACS Med Chem Lett. 2015 Dec 7;7(2):139-44. doi: 10.1021/acsmedchemlett.5b00378. eCollection 2016 Feb 11.
6
Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform.
Nucleic Acids Res. 2016 May 19;44(9):e88. doi: 10.1093/nar/gkw089. Epub 2016 Feb 17.
7
Targeting EZH2 in cancer.
Nat Med. 2016 Feb;22(2):128-34. doi: 10.1038/nm.4036.
8
A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1.
Nat Chem Biol. 2016 Mar;12(3):180-7. doi: 10.1038/nchembio.2007. Epub 2016 Jan 25.
9
Regulation of gene transcription by Polycomb proteins.
Sci Adv. 2015 Dec 4;1(11):e1500737. doi: 10.1126/sciadv.1500737. eCollection 2015 Dec.
10
PRC2 mediated H3K27 methylations in cellular identity and cancer.
Curr Opin Cell Biol. 2015 Dec;37:42-8. doi: 10.1016/j.ceb.2015.10.003. Epub 2015 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验